JANE MEHL: Open Payments
NPI 1881267375 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 35 payments from 11 companies in 2025. Trend: 2023 $784 · 2024 $549 · 2025 $1,249
Food & beverage: $1,148Education: $101
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $339 |
| Teva Pharmaceuticals USA, Inc. | 6 | $280 |
| ABBVIE INC. | 10 | $263 |
| Janssen Pharmaceuticals, Inc | 2 | $123 |
| Indivior Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Neuronetics, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Braeburn Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: ARISTADA, VRAYLAR, MAVYRET, UZEDY, INVEGA SUSTENNA, LYBALVI, SUBLOCADE, AUSTEDO XR.
Industry payments across CO — which companies pay providers there.
